ReviewHeart failure reviews2014
Co-morbidities in heart failure.
Review in Heart failure reviews, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- A systematic review and meta-analysis of the impact of mineralocorticoid receptor antagonists on glucose homeostasis.Medicine · 2017Pooled it
- Validity of heart failure diagnoses in administrative databases: a systematic review and meta-analysis.PloS one · 2014Pooled it
- Comprehensive geriatric assessment identifies multidimensional vulnerabilities in older adults with heart failure.Turkish journal of medical sciences · 2026Article
- Impact of Comorbidity Clusters on Quality of Life in Chronic Heart Failure.Vascular health and risk management · 2026Article
- Predicting Quality of Life of Patients in Romania with Heart Failure with Preserved Ejection Fraction by Analyzing H2FPEF Scores.Healthcare (Basel, Switzerland) · 2025Article
- An Updated Review of the Management of Chronic Heart Failure in Patients with Chronic Kidney Disease.Reviews in cardiovascular medicine · 2024Review
- Predictors of mortality in heart failure with reduced ejection fraction: interaction between diabetes mellitus and impaired renal function.International urology and nephrology · 2023Article
- Hyperpolypharmacy is a predictor of mortality after left ventricular assist device (LVAD) implantation.American heart journal plus : cardiology research and practice · 2022Article
- Informal Caregivers' Experiences with Performing Telemonitoring in Heart Failure Care at Home-A Qualitative Study.Healthcare (Basel, Switzerland) · 2022Article
- Noncardiac comorbidity clustering in heart failure: an overlooked aspect with potential therapeutic door.Heart failure reviews · 2022Review
- Evidence-Based Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction and Chronic Kidney Disease.Circulation · 2022Review
- The Prognostic Value of Anemia in Patients with Preserved, Mildly Reduced and Recovered Ejection Fraction.Diagnostics (Basel, Switzerland) · 2022Article
- Perioperative Sensor and Algorithm Programming in Patients with Implanted ICDs and Pacemakers for Cardiac Resynchronization Therapy.Sensors (Basel, Switzerland) · 2021Article
- Time-to-event prediction analysis of patients with chronic heart failure comorbid with atrial fibrillation: a LightGBM model.BMC cardiovascular disorders · 2021Article
- Predictive value of HESC heart failure · 2021Article
- Impact of non-cardiovascular comorbidities on the quality of life of patients with chronic heart failure: a scoping review.Health and quality of life outcomes · 2020Article
- Cardiorenal sodium MRI in small rodents using a quadrature birdcage volume resonator at 9.4 T.Magma (New York, N.Y.) · 2020Article
- Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry.Clinical research in cardiology : official journal of the German Cardiac Society · 2019Article
- Article
- Hydrogen Sulfide Attenuates Renin Angiotensin and Aldosterone Pathological Signaling to Preserve Kidney Function and Improve Exercise Tolerance in Heart Failure.JACC. Basic to translational science · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Heart failure is a clinical syndrome characterized by poor quality of life and high morbidity and mortality. Co-morbidities frequently accompany heart failure and further decrease in both quality of life and clinical outcome. We describe that the prevalence of co-morbidities in patients with heart failure is much higher compared to age-matched controls. We will specifically address the most studied organ-related co-morbidities, that is, renal dysfunction, cerebral dysfunction, anaemia, liver dysfunction, chronic obstructive pulmonary disease, diabetes mellitus and sleep apnoea. The pathophysiologic processes underlying the interaction between heart failure and co-morbid conditions are complex and remain largely unresolved. Although common risk factors are likely to contribute, it is reasonable to believe that factors associated with heart failure might cause other co-morbid conditions. Inflammation, neurohumoral pathway activation and hemodynamic changes are potential factors. We try to provide explanations for the observed association between co-morbidities and heart failure, as well as its impact on survival.
Indexed as
Identifiers
23266884What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.